Levofloxacin Fresenius Kabi

Levofloxacin, the active ingredient in Levofloxacin Fresenius Kabi, is a fluoroquinolone antibiotic presented as an injection for intravenous use. It treats a range of bacterial infections in adults and children when prescribed by a qualified health professional.

GNH USA supplies Levofloxacin Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levofloxacin is a fluoroquinolone antibiotic used to treat infections caused by susceptible bacteria.

- Community‑acquired pneumonia: achieves clinical cure and bacterial eradication in typical cases. - Hospital‑acquired pneumonia: effective against resistant pathogens in severe respiratory infections. - Complicated urinary tract infections: resolves infection and prevents recurrence. - Complicated intra‑abdominal infections: supports surgical and medical management of polymicrobial infections. - Skin and soft tissue infections: clears bacterial involvement in cellulitis and abscesses. - Acute bacterial sinusitis: reduces symptoms and promotes sinus clearance.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: transient gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: mild to moderate intensity. - Dizziness: occasional vertigo or light‑headedness. - Rash: mild skin erythema or pruritus. - Elevated liver enzymes: transient laboratory changes.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles, requiring immediate discontinuation. - QT interval prolongation: risk of ventricular arrhythmias. - Clostridioides difficile infection: severe colitis may develop. - Severe allergic reactions: anaphylaxis, angioedema. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: life‑threatening skin reactions. - Peripheral neuropathy: persistent sensory deficits.

Levofloxacin requires careful assessment before use to minimize risks.

- Assess renal function: adjust dosing in patients with impaired clearance. - Monitor for tendon pain or swelling: discontinue if symptoms appear. - Avoid use in patients with known hypersensitivity to fluoroquinolones. - Use with caution in pregnancy (Category C): only if benefits outweigh potential risks. - Avoid concomitant QT‑prolonging drugs: monitor cardiac rhythm. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with several medicines, influencing safety and efficacy.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption. - Warfarin: may increase INR, requiring close coagulation monitoring. - Co‑administration with other fluoroquinolones: heightened tendon toxicity risk. - Drugs that prolong QT interval (e.g., macrolides, antiarrhythmics): increase arrhythmia potential.

Moderate Interactions (Monitor Closely): - Corticosteroids: elevate tendon rupture risk, monitor musculoskeletal symptoms. - Theophylline: may raise plasma levels, watch for toxicity signs. - Cyclosporine: can increase levofloxacin concentrations, adjust dosing as needed.